NCT00004051View on ClinicalTrials.gov

Irinotecan in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

July 31, 2001

Study Completion Date

December 31, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004051 - Irinotecan in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter